BIOMET 3I

Manufacturer adverse-event records for BIOMET 3I come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2007–2025 · mid-book · quiet Death-code · injury-heavy

Death-code intensity

BIOMET 3I is quieter on Death-coded events

Death-coded event_type rows are 0 of 18,760 (0.00% · quiet tercile among 434 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for BIOMET 3I

The standout signal for BIOMET 3I is Death-code intensity: 0.00% of 18,760 reports (quiet tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for BIOMET 3I. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 12,395 (66.1% of event_type total). Peak single-year volume reaches 3,034 reports across 18 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

18,760
Total Reports
0
Event-type Death
12,395
Injury Reports
20
Device Types

Event Types

Injury 12,395 (66.1%)
Malfunction 6,364 (33.9%)
1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 10,896 (58.0%)
7,644 (40.7%)
Other 192 (1.0%)
R 23 (0.1%)
Hospitalization 17 (0.1%)
Congenital Anomaly 2 (0.0%)
H 1 (0.0%)
Death 1 (0.0%)

Yearly Trend

07
2007: 2
08
2008: 1
10
2010: 3
11
2011: 2
12
2012: 4
13
2013: 148
14
2014: 183
15
2015: 859
16
2016: 370
17
2017: 640
18
2018: 826
19
2019: 1,667
20
2020: 2,163
21
2021: 2,332
22
2022: 1,987
23
2023: 2,099
24
2024: 3,034
25
2025: 2,440